Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice
Abstract Background Wu-Mei-Wan (WMW) is a traditional Chinese herbal formulation that is clinically prescribed to treat diabetes mellitus in China. WMW has been shown to alleviate damage in pancreatic β cells, but the underlying mechanism remains unclear. This study aims to explore how WMW plays a p...
Saved in:
Main Authors: | Xueping Yang (Author), Fuer Lu (Author), Lingli Li (Author), Jingbin Li (Author), Jinlong Luo (Author), Siyi Zhang (Author), Xinqiao Liu (Author), Guang Chen (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wu-Mei-Wan Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization
by: Shuguang Yan, et al.
Published: (2022) -
Traditional herbal formula Wu-Mei-Wan alleviates TNBS-induced colitis in mice by inhibiting necroptosis through increasing RIPK3 O-GlcNAcylation
by: Fan Wu, et al.
Published: (2021) -
Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving β cell function and reducing insulin resistance in diabetic rats
by: Guang Chen, et al.
Published: (2017) -
Hydrogen-Rich Saline Inhibits NLRP3 Inflammasome Activation and Attenuates Experimental Acute Pancreatitis in Mice
by: Jian-Dong Ren, et al.
Published: (2014) -
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
by: Pengfei Chen, et al.
Published: (2024)